Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
- June -
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
- 2016 -
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
June 2016 - 71 products
IP
Oxycodon-Naloxon Sandoz 60
mg/30 mg
30
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
A+
FB
G
IP
Oxycodon-Naloxon Sandoz 60
mg/30 mg
60
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
A+
FB
G
IP
Oxycodon-Naloxon Sandoz 80
mg/40 mg
30
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
A+
FB
G
IP
Oxycodon-Naloxon Sandoz 80
mg/40 mg
60
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
A+
FB
G
IP
CI
Oxycodon-Naloxon Sandoz 5
mg/2.5mg
30
9.13
26.35
10 %
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
CI
Oxycodon-Naloxon Sandoz 5
mg/2.5mg
60
16.06
33.90
10 %
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Oxycodon-Naloxon Sandoz 10
mg/5mg
30
13.94
31.60
10 %
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Oxycodon-Naloxon Sandoz 10
mg/5mg
60
24.51
43.05
10 %
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Oxycodon-Naloxon Sandoz 20
mg/10mg
30
23.51
42.00
10 %
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Oxycodon-Naloxon Sandoz 20
mg/10mg
60
44.94
65.30
10 %
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Oxycodon-Naloxon Sandoz 40
mg/20mg
30
43.53
63.75
10 %
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Oxycodon-Naloxon Sandoz 40
mg/20mg
60
84.08
107.85
10 %
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
L
IP
CI
CM
Linezolid Pfizer 600 mg
10
424.39
477.95
10 %
Coated tablets: Linezolidum 600 mg
Pfizer AG
A / SL / SG
FB
G
L
IP
CI
Valsartan Amlo Spirig HC
5/80mg
28
12.49
29.95
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Valsartan Amlo Spirig HC
5/80mg
98
40.38
60.15
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Valsartan Amlo Spirig HC
5/160mg
28
14.83
32.50
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Valsartan Amlo Spirig HC
5/160mg
98
51.84
72.55
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Valsartan Amlo Spirig HC
10/160mg
28
14.83
32.50
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Valsartan Amlo Spirig HC
10/160mg
98
51.84
72.55
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Hydroxycarbamid Labatec 500 mg
50
29.72
48.75
10 %
Capsules: Hydroxycarbamidum 500 mg
Labatec Pharma SA
A / SL / SG
FB
G
IP
CI
Hydroxycarbamid Labatec 500 mg
100
59.44
81.05
10 %
Capsules: Hydroxycarbamidum 500 mg
Labatec Pharma SA
A / SL / SG
FB
G
L
IP
CI
CM
Linezolid Pfizer 20 mg/ml
150 ml
219.17
254.80
10 %
Granulat zur Herstellung einer Suspension zum Einnehmen: Linezolidum 20 mg
Pfizer AG
A / SL / SG
FB
G
L
IP
CM
Linezolid Pfizer 2 mg/mI
10 x 300 ml
491.27
550.70
10 %
lnfusionslösung: Linezolidum 2 mg/ml
Pfizer AG
●
A / SL / SG
FB
G
L
IP
PP
Elocta 250 I.E.
Set(s)
186.30
232.20
10 %
Lyophilisate and solvent: Efmoroctocogum Alfa 250 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
PP
Elocta 500 I.E.
Set(s)
372.60
423.35
10 %
Lyophilisate and solvent: Efmoroctocogum Alfa 500 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
PP
Elocta 1000 I.E.
Set(s)
745.20
805.65
10 %
Lyophilisate and solvent: Efmoroctocogum Alfa 1000 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
PP
Elocta 1500 I.E.
Set(s)
1117.80
1187.90
10 %
Lyophilisate and solvent: Efmoroctocogum Alfa 1500 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
PP
Elocta 2000 I.E.
Set(s)
1490.40
1570.20
10 %
Lyophilisate and solvent: Efmoroctocogum Alfa 2000 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
PP
Elocta 3000 I.E.
Set(s)
2235.60
2334.75
10 %
Lyophilisate and solvent: Efmoroctocogum Alfa 3000 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
PP
Elocta 4000 I.E.
2980.80
3099.35
10 %
Lyophilisate and solvent: Efmoroctocogum Alfa 4000 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
PP
Obizur 500 E
500 IE
1225.95
1298.85
10 %
Lyophilisate and solvent: Susoctocogum Alfa 500 U
Takeda Pharma AG
B / SL
FB
G
L
IP
PP
Empliciti 300 mg
1002.54
1106.75
10 %
Lyophilisate: Elotuzumabum 300 mg
Bristol-Myers Squibb SA
A / SL
FB
G
L
IP
PP
Empliciti 400 mg
1336.72
1470.20
10 %
Lyophilisate: Elotuzumabum 400 mg
Bristol-Myers Squibb SA
A / SL
FB
G
IP
CI
PP
Brintellix 5 mg
28
21.86
40.20
10 %
Coated tablets: Vortioxetinum 5 mg
Lundbeck (Schweiz) AG
B / SL
FB
G
IP
CI
PP
Brintellix 10 mg
28
37.42
57.10
10 %
Coated tablets: Vortioxetinum 10 mg
Lundbeck (Schweiz) AG
B / SL
FB
G
IP
CI
PP
Brintellix 10 mg
98
130.12
157.95
10 %
Coated tablets: Vortioxetinum 10 mg
Lundbeck (Schweiz) AG
B / SL
FB
G
IP
CI
PP
Brintellix 20 mg
28
63.28
85.25
10 %
Coated tablets: Vortioxetinum 20 mg
Lundbeck (Schweiz) AG
B / SL
FB
G
IP
CI
PP
Brintellix 20 mg
9 x 7
141.66
170.50
10 %
Coated tablets: Vortioxetinum 20 mg
Lundbeck (Schweiz) AG
B / SL
FB
G
IP
CI
PP
Brintellix 20 mg
98
219.24
254.85
10 %
Coated tablets: Vortioxetinum 20 mg
Lundbeck (Schweiz) AG
B / SL
FB
G
L
IP
CI
Triveram 10 / 5 / 5 mg
30
24.75
43.35
10 %
Coated tablets: 3 Active Agents
Servier (Suisse) SA
B / SL
FB
G
L
IP
CI
Triveram 10 / 5 / 5 mg
90
63.11
85.05
10 %
Coated tablets: 3 Active Agents
Servier (Suisse) SA
B / SL
FB
G
L
IP
CI
Triveram 20 / 5 / 5 mg
30
24.75
43.35
10 %
Coated tablets: 3 Active Agents
Servier (Suisse) SA
B / SL
FB
G
L
IP
CI
Triveram 20 / 5 / 5 mg
90
63.11
85.05
10 %
Coated tablets: 3 Active Agents
Servier (Suisse) SA
B / SL
FB
G
L
IP
CI
Triveram 20 / 10 / 5 mg
30
24.75
43.35
10 %
Coated tablets: 3 Active Agents
Servier (Suisse) SA
B / SL
FB
G
L
IP
CI
Triveram 20 / 10 / 5 mg
90
63.11
85.05
10 %
Coated tablets: 3 Active Agents
Servier (Suisse) SA
B / SL
FB
G
L
IP
CI
Triveram 20 / 10 / 10 mg
30
24.75
43.35
10 %
Coated tablets: 3 Active Agents
Servier (Suisse) SA
B / SL
FB
G
L
IP
CI
Triveram 20 / 10 / 10 mg
90
63.11
85.05
10 %
Coated tablets: 3 Active Agents
Servier (Suisse) SA
B / SL
FB
G
L
IP
CI
Triveram 40 / 10 / 10 mg
30
24.75
43.35
10 %
Coated tablets: 3 Active Agents
Servier (Suisse) SA
B / SL
FB
G
L
IP
CI
Triveram 40 / 10 / 10 mg
90
63.11
85.05
10 %
Coated tablets: 3 Active Agents
Servier (Suisse) SA
B / SL
FB
G
IP
CI
Urotec 8 mg
30
11.99
29.45
10 %
Capsules: 2 Active Agents
Recordati AG
B / SL
FB
G
IP
CI
Urotec 8 mg
100
37.87
57.60
10 %
Capsules: 2 Active Agents
Recordati AG
B / SL
FB
G
IP
CI
Urorec 4 mg
30
11.99
29.45
10 %
Capsules: Silodosinum 4 mg
Recordati AG
B / SL
FB
G
IP
CI
Urorec 4 mg
100
37.87
57.60
10 %
Capsules: Silodosinum 4 mg
Recordati AG
B / SL
FB
G
L
IP
PP
MabThera subkutan 1600
mg/13.4 ml
2023.78
2217.40
10 %
Lösung zur subkutanen Injektion: Rituximabum 1600mg / 13.4ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
PP
MabThera subkutan 1400
mg/11.7 ml
1516.83
1666.05
10 %
Lösung zur subkutanen Injektion: Rituximabum 1400mg / 11.7ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
IP
CI
PP
Brintellix 20 mg/ml
15 ml
40.55
60.50
10 %
Tropfen zum Einnehmen: Vortioxetinum 20 mg/ml
Lundbeck (Schweiz) AG
B / SL
FB
G
IP
PP
Elocta 750 I.E.
PR
PR
k.A.
Lyophilisate and solvent: Efmoroctocogum Alfa 750 UI
Swedish Orphan
Biovitrum AG
B
FB
G
IP
PP
Obizur 500 E
500 IE
PR
PR
k.A.
Lyophilisate and solvent: Susoctocogum Alfa 500 U
Takeda Pharma AG
B
FB
G
IP
PP
Obizur 500 E
500 IE
PR
PR
k.A.
Lyophilisate and solvent: Susoctocogum Alfa 500 U
Takeda Pharma AG
B
FB
G
IP
CI
Oxycodon-Naloxon Sandoz 5
mg/2.5mg
60
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
A+
FB
G
IP
Oxycodon-Naloxon Sandoz 10
mg/5mg
60
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
A+
FB
G
IP
Oxycodon-Naloxon Sandoz 20
mg/10mg
60
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
A+
FB
G
IP
Oxycodon-Naloxon Sandoz 30
mg/15mg
30
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
A+
FB
G
IP
Oxycodon-Naloxon Sandoz 30
mg/15mg
60
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
A+
FB
G
IP
Oxycodon-Naloxon Sandoz 30
mg/15mg
60
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
A+
FB
G
IP
Oxycodon-Naloxon Sandoz 40
mg/20mg
60
PR
PR
k.A.
Delayed release tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
A+
FB
G
IP
CI
PP
Brintellix 15 mg
28
PR
PR
k.A.
Coated tablets: Vortioxetinum 15 mg
Lundbeck (Schweiz) AG
B
FB
G
IP
CI
PP
Brintellix 15 mg
98
PR
PR
k.A.
Coated tablets: Vortioxetinum 15 mg
Lundbeck (Schweiz) AG
B
FB
G
IP
CI
Hydroxycarbamid Labatec 500 mg
30
PR
PR
k.A.
Capsules: Hydroxycarbamidum 500 mg
Labatec Pharma SA
A
FB
G
IP
CI
Urotec 8 mg
10
PR
PR
k.A.
Capsules: 2 Active Agents
Recordati AG
B
FB
G
IP
CI
Urorec 4 mg
10
PR
PR
k.A.
Capsules: Silodosinum 4 mg
Recordati AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
